Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Has results × Endocrine Tumors × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1578 Neoplasms 1145 Carcinoma, Non-Small-Cell Lung 1060 Prostatic Neoplasms 863 Multiple Myeloma 687 Leukemia, Myeloid, Acute 625 Neoplasm Metastasis 582 Lung Neoplasms 553 Colorectal Neoplasms 553 Melanoma 540 Lymphoma 521 Leukemia 479 Lymphoma, Non-Hodgkin 466 Leukemia, Lymphocytic, Chronic, B-Cell 431 Ovarian Neoplasms 426 Pancreatic Neoplasms 410 Precursor Cell Lymphoblastic Leukemia-Lymphoma 388 Recurrence 377 Myelodysplastic Syndromes 342 Lymphoma, Follicular 330 Head and Neck Neoplasms 317 Brain Neoplasms 313 Carcinoma, Renal Cell 312 Glioblastoma 309 Lymphoma, Large B-Cell, Diffuse 299 Hodgkin Disease 276 Carcinoma, Hepatocellular 271 Squamous Cell Carcinoma of Head and Neck 252 Lymphoma, Mantle-Cell 245 Sarcoma 222

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00353496 2025-03-05

CLARINET

Ipsen

Phase 3 Completed

264 enrolled 17 charts

Endocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡